Executable network of SARS-CoV-2-host interaction predicts drug combination treatments
Abstract The COVID-19 pandemic has pushed healthcare systems globally to a breaking point.The urgent need for effective and affordable COVID-19 treatments calls for repurposing combinations of approved drugs.The challenge is to identify which combinations are likely to be most effective and at what stages of the disease.Here, we present the first d